Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

The object of this trial is to evaluate the efficacy of D07001-softgel capsules + capecitabine compared with placebo + capecitabine by overall survival (OS). Eligible patients with advanced biliary tract cancer (BTC) will be randomized (1:1:1) to receive either 60 mg D07001-softgel, 100 mg D07001-softgel, or placebo, combine with capecitabine. Treatment will be continued until disease progression, death, withdraw consent, or completing 12 treatment cycles , whichever occurs first.

Participants needed: 195
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: InnoPharmax Inc.Updated: Jun 11, 2026Locations: 2
Eligibility criteria

Provide written informed consent prior to any study procedures and agree to adhe... [+22]

Participant has a diagnosis of active malignancy other than BTC within the past... [+19]

Read more
Status: Recruiting

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

The primary objective are: To assess the safety and tolerability of the combination of D07001-softgel capsules and Xeloda/TS-1. To evaluate the efficacy of the combination of D07001-softgel capsules and Xeloda/TS-1, as assessed by disease control rate (DCR).

Participants needed: 180
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: InnoPharmax Inc.Updated: Apr 30, 2025Locations: 5
Eligibility criteria

Male or female patients aged 18 years or older at screening (aged 20 years or ol... [+19]

Have prior chemotherapy regimen other than first line gemcitabine and cisplatin-... [+21]

Read more